Home

services

Our services: finding a buyer for shareholders who want to be acquired

Subject: Industry

12.04.2023
services

Our services: de-merger

Subject: Industry

08.03.2023
services

Our services: capital raising for fast growing companies

Subject: Healthcare

08.02.2023
services

Our services: deal negotiations assistance and due diligence

Subject: Technology

11.01.2023
quantum computing

Our article: Quantum computing - the current state of the industry

Subject: Technology

27.12.2022
ewbs

Our podcast with BioCentury: East-West Highlights

Subject: Healthcare

06.12.2022
cc

Our deals: Cambridge Cognition enters in a strategic partnership with Luca Healthcare

Subject: Healthcare

29.11.2022
legal tech

Our article: Legal tech is the future, and it's here today

Subject: Technology

28.11.2022
ewbs

Our sponsorship with BioCentury at East-West Biopharma Summit

Subject: Healthcare

15.11.2022
mdc

Our session with MDC at the Berlin Science Week

Subject: Healthcare

14.11.2022
ewbs

Our panel at East-West Summit

Subject: Healthcare

02.11.2022
ETHERNA

Client news: eTheRNA Immunotherapeutics has raised 39M Euro in Series B2

Subject: Healthcare

26.09.2022
Investsuite

Our deals: Investsuite raised a 6M Euro Series A financial round

Subject: Technology

23.09.2022
Join us!

We're hiring!

Subject: Healthcare,  Technology,  Industry,  General

07.09.2022
miracor

Client news: Miracor announces FDA IDE approval for PiCSO pivotal study

Subject: Healthcare

24.08.2022
Yen

Podcast with Caesar Hao: The Voice of Hao

Subject: Healthcare

19.08.2022
AcademicLabs

AGIO Capital and Business Solutions and AcademicLabs sign a strategic partnership agreement

Subject: Healthcare

13.06.2022
welkin meraki

Our deals: Welkin and Meraki acquired by Industrious Office

Subject: Industry

31.05.2022
Hackathon

Our team member won the Cronos Groep-SINC Hackathon

Subject: Technology

27.05.2022
ls leader

Article Life Science Leader: Recognizing the Value of Biotech Partnerships in China

Subject: Healthcare

22.05.2022
Agio party

Our event with Agio Legal and Agio Finance

Subject: General

13.05.2022
FCCC

Online Masterclass: Understanding China's Healthcare market and its evolutions

Subject: Healthcare

05.05.2022
agio s

Our strategy meeting

Subject: General

04.05.2022
biotech

Our article in Bloovi: De Chinese gezondheidssector boomt en dat schept kansen voor Belgische biotech- en medtechbedrijven

Subject: Healthcare

27.04.2022
Our session at Innovation for Health: Access Biotech China

Our session at Innovation for Health: Access Biotech China

Subject: Healthcare

08.04.2022
international womens day

International Women's Day at AGIO Capital

Subject: General

08.03.2022
Mybio article

Report MyBio: 2021 China Pharma BD Transactions Annual Report

Subject: Healthcare

04.03.2022
Our article in Etion's Geëngageerd Ondernemen: De Chinese bril

Our article in Etion's Geëngageerd Ondernemen: De Chinese bril

Subject: General

02.02.2022
Our podcast with Biocentury & Bayhelix: takeaways on the 8th China Healthcare Summit

Our podcast with Biocentury & Bayhelix: takeaways on the 8th China Healthcare Summit

Subject: Healthcare

17.11.2021
Chinese Life Sciences sector, landscape, hubs, opportunities & future expectations

Our session at ABC: Chinese Life Sciences sector, landscape, hubs, opportunities & future expectations

Subject: Healthcare

14.10.2021
Chinese big tech is dead, long live innovation

Our article in De Tijd: Chinese big tech is dead, long live innovation

Subject: Technology

07.10.2021
Worg Pharmaceuticals to acquire Apitope International

Our deals: Worg Pharmaceuticals to acquire Apitope International

Subject: Healthcare

03.10.2021
Article Reuters: Analysis: China's biotech sector comes of age with big licensing deals, global ambitions

Article Reuters: Analysis: China's biotech sector comes of age with big licensing deals, global ambitions

Subject: Healthcare

20.09.2021
Biocentury Article: The mRNA therapeutics pipeline: Data Byte

Article Biocentury: The mRNA therapeutics pipeline: Data Byte

Subject: Healthcare

03.09.2021
Complix’s closes Global Drug Development Deal with Jiangsu Nhwa Pharma

Our deals: Complix’s closes Global Drug Development Deal with Jiangsu Nhwa Pharma

Subject: Healthcare

28.07.2021
Our article in Mediaplanet's Life Sciences editorial together with Complix

Our article in Mediaplanet's Life Sciences editorial together with Complix

Subject: Healthcare

19.04.2021
Beijing has a plan, Brussels and Washington don't...

Our article in De Tijd: Beijing has a plan, Brussels and Washington don't...

Subject: General

12.04.2021
Our article in MT Magazine: China is taking the lead in times of Corona

Our article in MT Magazine: China is taking the lead in times of Corona

Subject: General

26.03.2021
Our deals: OMV closes deal with Constructel

Our deals: OMV closes deal with Constructel

Subject: Industry

23.03.2021
Our deals: Complix Signs Global Drug Discovery and Development Agreement with I-Mab

Our deals: Complix Signs Global Drug Discovery and Development Agreement with I-Mab

Subject: Healthcare

15.03.2021
Our deals: Futura Medical closes deal with Co-High

Our deals: Futura Medical enters in licensing agreement with Co-High

Subject: Healthcare

05.03.2021
Our article in FOKUS Business Guid: Blik op Azië

Our article in FOKUS Business Guid: Blik op Azië

Subject: General

16.02.2021
AGIO joined BioIndustry Association

AGIO joined BioIndustry Association

Subject: Healthcare

07.01.2021
bridge between east and west

Our article in Biovox - A bridge from East to West - linking Chinese and European biotech

Subject: Healthcare

03.12.2020
Our deals: eTheRNA immunotherapies and China Grand Pharmaceutical set up AuroRNA

Our deals: eTheRNA immunotherapies and China Grand Pharmaceutical set up AuroRNA

Subject: Healthcare

02.12.2020
klv

Our deals: KLV LED Light Solutions supported by us

Subject: Industry

18.11.2020
Our deals: China partnership between Octimet Oncology and Shanghai Allist Pharmaceuticals

Our deals: China partnership between Octimet Oncology and Shanghai Allist Pharmaceuticals

Subject: Healthcare

17.09.2020
A record-breaking year for investments in Belgian Biotech & Medtech companies

A record-breaking year for investments in Belgian Biotech & Medtech companies

Subject: Healthcare

08.09.2020
Our article in Agoria: Coronavirus in China not only dangers, but also creates new opportunities

Our article in Agoria: Coronavirus in China not only dangers, but also creates new opportunities

Subject: General

08.09.2020
Our deals: Miracor Medical

Our deals: Miracor Medical closes deal with Yonghua for series E round

Subject: Healthcare

02.09.2020
Our article in Bloovi: How China managed to control Corona

Our article in Bloovi: How China managed to control Corona

Subject: General

05.08.2020
Agio Capital & Business Solutions successfully supported eTheRNA immunotherapies

Our deals: eTheRNA immunotherapies closes series B investment round

Subject: Healthcare

16.06.2020
Belgian Princely Mission to China

Belgian Princely Mission to China

Subject: Healthcare

16.11.2019
Our article in De Tijd: The growth of the Chinese pharma market

Our article in De Tijd: The growth of the Chinese pharma market

Subject: Healthcare

31.10.2019
Our article in Biovox: A bridge from east to west - linking Chinese investors with European companies

Our article in Biovox: A bridge from east to west - linking Chinese investors with European companies

Subject: Healthcare

24.10.2019
Our article with VOKA: Let´s innovate together with China

Our article with VOKA: Let´s innovate together with China

Subject: Technology

12.02.2019
Our partnership with Agoria

Our partnership with Agoria

Subject: Technology

10.02.2019
Our deals: Promethera Biosciences supported by Co-High Medical Investment Fund

Our deals: Promethera Biosciences supported by Co-High Medical Investment Fund

Subject: Healthcare

05.01.2019
Article Techcrunch: China VC has overtaken Silicon Valley

Article Techcrunch: China VC has overtaken Silicon Valley

Subject: Technology,  General

28.07.2018

Stay up to date

I have read and I agree to the privacy policy.